The current TELO market cap is 142.72M. The company's latest EPS is USD -0.4415 and P/E is -10.92.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -1.08M | -1.92M | -1.47M |
Net Income | -9.33M | -6.26M | -1.45M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -138k | -854k | -3.94M |
Net Income | -138k | -854k | -13.07M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 4.77M | 3.5M | 2.1M |
Total Liabilities | 1.34M | 486k | 534k |
Total Equity | 3.44M | 3.02M | 1.57M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 0 | 49k | 4.77M |
Total Liabilities | 138k | 986k | 1.34M |
Total Equity | -138k | -937k | 3.44M |
Market Cap | 142.72M |
Price to Earnings Ratio | -10.92 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 41.51 |
Dividend Yield | - |
Shares Outstanding | 29.61M |
Average Volume (1 week) | 60.9k |
Average Volume (1 Month) | 174.59k |
52 Week Change | -31.14% |
52 Week High | 20.72 |
52 Week Low | 3.11 |
Spread (Intraday) | 0.2 (4.03%) |
Company Name | Telomir Pharmaceuticals Inc |
Address |
900 west platt street, suite 200 tampa, florida 33606 |
Website | https://www.telomirpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.